SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH LIRENTELIMAB, A MONOCLONAL ANTIBODY AGAINST SIGLEC-8, IN PATIENTS WITH EOSINOPHILIC GASTRITIS/DUODENITIS
Evan S. Dellon 1
Kathryn Peterson 2
Nirmala Gonsalves 3
Robert Genta 4
John Leung 5
Paneez Khoury 6
Amy Klion
Sabine Hazan 7
Adam Bledsoe 8
Sandy Durrani 9
Chao Wang 10
Camilla Shaw 11
Alan Chang
BHUPINDER SINGH
Amol Kamboj
Henrik Rasmussen
Ikuo Hirano
Mirna Chehade 12
Joseph Murray
Gary W. Falk 13
Michael F. Vaezi 14
Marc E. Rothenberg
1 University of North Carolina, Chapel Hill, United States
2 University of Utah, Salt Lake City, United States
3 Northwestern University, Chicago, United States
4 Baylor College of Medicine, Houston, United States
5 Tufts University, Boston, United States
6 NIAID/NIH, Bethesda, United States
7 Ventura Clinical Trials, Ventura, United States
8 Mayo Clinic Rochester, Rochester, United States
9 Cincinnati Children’s Hospital, University of Cincinnati College of Medicine, Cincinnati, United States
10 Pharma Data Associates, Piscataway, United States
11 Allakos, Inc., Redwood City, United States
12 Icahn School of Medicine at Mount Sinai, New York, United States
13 University of Pennsylvania Perelman School of Medicine, Philadelphia, United States
14 Vanderbilt University, Nashville, United States
Topic
Immunology, Oesophagus, Paediatrics
Conference
UEG Week Virtual 2021
Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]